BR-A-657

DRUG2 trials

Sponsors

Boryung Pharmaceutical Co., Ltd

Conditions

Essential Hypertension

Phase 1

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

CompletedNCT01289899

Boryung Pharmaceutical Co., LtdEssential Hypertension

Start: 2004-01-31End: 2004-02-29Updated: 2011-02-04

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

CompletedNCT01289886

Boryung Pharmaceutical Co., LtdEssential Hypertension

Start: 2003-09-30End: 2003-12-31Updated: 2011-02-04